The global overactive bladder (OAB) therapeutics market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market growth includes an rising incidences of overactive bladder disorder coupled with an aging population. Moreover, manufacturers are continuously increasing their R&D expenditure to develop novel drugs such as neuromuscular blocking agents with innovative mechanisms of action, which in turn is expected to fuel the growth of the global overactive bladder (OAB) therapeutics market. In addition, the development of innovative intravesical therapies is further driving the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/overactive-bladder-oab-therapeutics-market
Therapy approvals are regulated by various regional regulatory authorities. The changing regulatory scenario favoring overactive bladder treatments in a number of countries, such as UK and Japan, will offer significant growth opportunities for market players. For instance, the UK’s National Institutes for Health and Care Excellence (NICE) reimburses the BOTOX therapy. In 2007, the Japanese Ministry of Health, Labour and Welfare (MHLW) launched an action plan to promote the safe use of generics. Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB include urgency, high urinary frequency, and urge incontinence. Anticholinergic agents are considered the first-line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs act by antagonizing cholinergic receptors that provide relief from frequent urination.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape: Allergan plc, Astellas Pharma Inc., and Teva Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Overactive Bladder (OAB) Therapeutics Market Report by Segment
By Type
- Anticholinergic Agents
- Beta-3 Adrenoreceptor Agonists
By Application
- Hospitals
- Clinics
- Others
A full report of Overactive Bladder (OAB) Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/overactive-bladder-oab-therapeutics-market
Overactive Bladder (OAB) Therapeutics Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Allergan plc
- Astellas Pharma Inc.
- Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
